Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Notes from Members

Autor: Avolio, Marco

Publikováno v: The Cactus and Succulent Journal of Great Britain, 1982 Jun 01. 44(2), 44-44.

Externí odkaz: https://www.jstor.org/stable/42786768

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients.

Autor: Leto SM; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Grassi E; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Avolio M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Vurchio V; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Cottino F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Ferri M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Zanella ER; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Borgato S; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Corti G; Department of Oncology, University of Torino, Candiolo, Torino, Italy., di Blasio L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Somale D; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Aptuit, an Evotec Company, Verona, Italy., Vara-Messler M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy.; Sanofi Belgium, Zwijnaarde, Belgium., Galimi F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Sassi F; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Lupo B; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Catalano I; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Pinnelli M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Viviani M; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Sperti L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Mellano A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy., Ferrero A; Mauriziano Umberto I Hospital, Torino, Italy., Zingaretti CC; Mauriziano Umberto I Hospital, Torino, Italy., Puliafito A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Primo L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy., Bertotti A; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy. andrea.bertotti@ircc.it.; Department of Oncology, University of Torino, Candiolo, Torino, Italy. andrea.bertotti@ircc.it., Trusolino L; Candiolo Cancer Institute - FPO IRCCS, Candiolo, Torino, Italy. livio.trusolino@ircc.it.; Department of Oncology, University of Torino, Candiolo, Torino, Italy. livio.trusolino@ircc.it.

Publikováno v: Nature communications [Nat Commun] 2024 Aug 29; Vol. 15 (1), pp. 7495. Date of Electronic Publication: 2024 Aug 29.